AIM-Harvard/TrialPanorama-filtered huggingface dataset:
Study 30343508 — intervention group
Group type: COMPARATOR
Intervention: Control group (not specified)
Number of subjects: 31
Study 27632051 — intervention group
Group type: EXPERIMENTAL
Intervention: Multi-disciplinary rehabilitation
Number of subjects: 187
Study 24804989 — intervention group
Group type: EXPERIMENTAL
Intervention: A-NBIME
Number of subjects: 100
Study 24804989 — intervention group
Group type: COMPARATOR
Intervention: CV-MCE
Number of subjects: 100
Study 25622638 — intervention group
Group type: EXPERIMENTAL
Intervention: 1.9 µm Vela Laser
Number of subjects: 30
Study 25622638 — intervention group
Group type: COMPARATOR
Intervention: High-frequency electronic knife
Number of subjects: 30
Study 21833823 — intervention group
Group type: EXPERIMENTAL
Intervention: Pro-social priming
Number of subjects: 0
Study 21833823 — intervention group
Group type: COMPARATOR
Intervention: Non-social priming
Number of subjects: 0
Study 19278415 — intervention group
Group type: EXPERIMENTAL
Intervention: Nurse-led follow-up
Number of subjects: 4
Study 19278415 — intervention group
Group type: EXPERIMENTAL
Intervention: Nurse-led telephone follow-up
Number of subjects: 4
Study 19278415 — intervention group
Group type: EXPERIMENTAL
Intervention: Patient-initiated follow-up
Number of subjects: 4
Study 19278415 — intervention group
Group type: COMPARATOR
Intervention: Physician-led follow-up
Number of subjects: 4
Study 17575230 — intervention group
Group type: EXPERIMENTAL
Intervention: Pemetrexed 600 mg/m2 (P600 arm)
Number of subjects: 92
Study 17575230 — intervention group
Group type: EXPERIMENTAL
Intervention: Pemetrexed 900 mg/m2 (P900 arm)
Number of subjects: 92
Study 17575230 — intervention group
Group type: EXPERIMENTAL
Intervention: High thymidine phosphorylase expression
Number of subjects: 92
Study 17575230 — intervention group
Group type: EXPERIMENTAL
Intervention: Low thymidine phosphorylase expression
Number of subjects: 92
Study 17575230 — intervention group
Group type: EXPERIMENTAL
Intervention: High folylpolyglutamate synthetase expression
Number of subjects: 92
Study 17575230 — intervention group
Group type: EXPERIMENTAL
Intervention: Low folylpolyglutamate synthetase expression
Number of subjects: 92
Study 17575230 — intervention group
Group type: EXPERIMENTAL
Intervention: High gamma-glutamyl hydrolase expression
Number of subjects: 92
Study 17575230 — intervention group
Group type: EXPERIMENTAL
Intervention: Low gamma-glutamyl hydrolase expression
Number of subjects: 92
Study 15345866 — intervention group
Group type: EXPERIMENTAL
Intervention: Transcervical intrapartum amnioinfusion with saline
Number of subjects: 196
Study 15345866 — intervention group
Group type: COMPARATOR
Intervention: Routine obstetrical care
Number of subjects: 196
Study 11145633 — intervention group
Group type: EXPERIMENTAL
Intervention: Family History Screening Questionnaire (FHSQ) as part of a health check
Number of subjects: 100
Study 11145633 — intervention group
Group type: COMPARATOR
Intervention: Health check only (Control)
Number of subjects: 100
Study 9626829 — intervention group
Group type: EXPERIMENTAL
Intervention: Eptifibatide therapy (135-microg/kg bolus/0.5-microg/kg per min infusion or 135-microg/kg bolus/0.75-microg/kg per min infusion)
Number of subjects: 4010
Study 9626829 — intervention group
Group type: COMPARATOR
Intervention: Placebo (placebo bolus/placebo infusion)
Number of subjects: 4010
Study 9626829 — intervention group
Group type: EXPERIMENTAL
Intervention: Eptifibatide therapy
Number of subjects: 4010
Study 9626829 — intervention group
Group type: EXPERIMENTAL
Intervention: Advanced age
Number of subjects: 4010
Study 9626829 — intervention group
Group type: EXPERIMENTAL
Intervention: Longer time to sheath removal
Number of subjects: 4010
Study 9626829 — intervention group
Group type: EXPERIMENTAL
Intervention: Stent placement with intense post-stent anticoagulation
Number of subjects: 4010
Study 9626829 — intervention group
Group type: EXPERIMENTAL
Intervention: Female gender
Number of subjects: 4010
Study 9626829 — intervention group
Group type: EXPERIMENTAL
Intervention: PTCR within 24 h of thrombolytic therapy
Number of subjects: 4010
Study 9626829 — intervention group
Group type: EXPERIMENTAL
Intervention: Larger heparin doses during PTCR
Number of subjects: 4010
Study 9626829 — intervention group
Group type: EXPERIMENTAL
Intervention: Major coronary dissection
Number of subjects: 4010
Study 9626829 — intervention group
Group type: EXPERIMENTAL
Intervention: Placement of a venous sheath
Number of subjects: 4010
Study 7733514 — intervention group
Group type: EXPERIMENTAL
Intervention: Free amino acid diet (Group A)
Number of subjects: 20
Study 7733514 — intervention group
Group type: COMPARATOR
Intervention: Partial protein hydrolysate diet (Group B)
Number of subjects: 20
Study 7733514 — intervention group
Group type: EXPERIMENTAL
Intervention: Both groups (A and B)
Number of subjects: 20
Study 2625184 — intervention group
Group type: EXPERIMENTAL
Intervention: Left-sided or total colonoscopy in patients at risk (n = 104)
Number of subjects: 104
Study 2625184 — intervention group
Group type: COMPARATOR
Intervention: Control group (n = 104)
Number of subjects: 104
Study 2625184 — intervention group
Group type: EXPERIMENTAL
Intervention: Patients at risk (n = 104)
Number of subjects: 104
Study 2625184 — intervention group
Group type: EXPERIMENTAL
Intervention: Both groups
Number of subjects: 104
Study 810648 — intervention group
Group type: EXPERIMENTAL
Intervention: D-penicillamine therapy
Number of subjects: 80
Study 810648 — intervention group
Group type: COMPARATOR
Intervention: Control group treated with antirheumatic drugs
Number of subjects: 80
Study 810648 — intervention group
Group type: EXPERIMENTAL
Intervention: D-penicillamine and gold treatment
Number of subjects: 80
Study 810648 — intervention group
Group type: EXPERIMENTAL
Intervention: Immunosuppressive drugs
Number of subjects: 80
Study 31928034 — intervention group
Group type: EXPERIMENTAL
Intervention: Risk assessment information provided
Number of subjects: 340
Study 31928034 — intervention group
Group type: COMPARATOR
Intervention: No risk assessment information provided
Number of subjects: 340
Study 31000336 — intervention group
Group type: EXPERIMENTAL
Intervention: Honey dressings
Number of subjects: 40
Study 31000336 — intervention group
Group type: COMPARATOR
Intervention: Conventional dressings
Number of subjects: 40
Study 29140383 — intervention group
Group type: EXPERIMENTAL
Intervention: Amnion-Chorion Membranes (ACM)
Number of subjects: 22
Study 29140383 — intervention group
Group type: COMPARATOR
Intervention: Dense Polytetrafluoroethylene Membranes (dPTFE)
Number of subjects: 22
Study 25072441 — intervention group
Group type: EXPERIMENTAL
Intervention: Nonoperative treatment with antibiotics
Number of subjects: 50
Study 25072441 — intervention group
Group type: COMPARATOR
Intervention: Surgery
Number of subjects: 50
Study 22150529 — intervention group
Group type: EXPERIMENTAL
Intervention: High-frequency words
Number of subjects: 0
Study 22150529 — intervention group
Group type: EXPERIMENTAL
Intervention: Low-frequency words
Number of subjects: 0
Study 21106651 — intervention group
Group type: EXPERIMENTAL
Intervention: Risk communication (yes)
Number of subjects: 168
Study 21106651 — intervention group
Group type: EXPERIMENTAL
Intervention: Social norms communication (yes)
Number of subjects: 168
Study 21106651 — intervention group
Group type: COMPARATOR
Intervention: Combined message (risk + social norms)
Number of subjects: 168
Study 21106651 — intervention group
Group type: COMPARATOR
Intervention: Risk communication (no)
Number of subjects: 168
Study 21106651 — intervention group
Group type: COMPARATOR
Intervention: Social norms communication (no)
Number of subjects: 168
Study 19222841 — intervention group
Group type: EXPERIMENTAL
Intervention: 10 mg vardenafil administered orally twice a day for 12 weeks
Number of subjects: 42
Study 19222841 — intervention group
Group type: COMPARATOR
Intervention: Matching placebo administered orally twice a day for 12 weeks
Number of subjects: 42
Study 16863750 — intervention group
Group type: EXPERIMENTAL
Intervention: Pexelizumab
Number of subjects: 3099
Study 12779130 — intervention group
Group type: EXPERIMENTAL
Intervention: Arthroscopic lavage and arthroscopic debridement
Number of subjects: 0
Study 12779130 — intervention group
Group type: COMPARATOR
Intervention: Sham procedure
Number of subjects: 0
Study 11006204 — intervention group
Group type: EXPERIMENTAL
Intervention: 1% nitroprusside gel (5 mg)
Number of subjects: 36
Study 11006204 — intervention group
Group type: EXPERIMENTAL
Intervention: 2% nitroprusside gel (10 mg)
Number of subjects: 36
Study 11006204 — intervention group
Group type: COMPARATOR
Intervention: Placebo gel
Number of subjects: 36
Study 9182442 — intervention group
Group type: EXPERIMENTAL
Intervention: Systemic chemotherapy with cisplatin, methotrexate, and vinblastine (CMV) after TUR, aiming for vesical preservation (Arm A, n = 20)
Number of subjects: 37
Study 9182442 — intervention group
Group type: COMPARATOR
Intervention: Chemotherapy with CMV after TUR followed by cystectomy (Arm B, n = 17)
Number of subjects: 37
Study 8374255 — intervention group
Group type: EXPERIMENTAL
Intervention: Torasemide (20 mg/day)
Number of subjects: 28
Study 8374255 — intervention group
Group type: COMPARATOR
Intervention: Furosemide (50 mg/day)
Number of subjects: 28
Study 3565115 — intervention group
Group type: EXPERIMENTAL
Intervention: Lay facilitators
Number of subjects: 116
Study 3565115 — intervention group
Group type: COMPARATOR
Intervention: Doctoral counseling students
Number of subjects: 116
Study 30595777 — intervention group
Group type: EXPERIMENTAL
Intervention: Pulsed radiofrequency
Number of subjects: 118
Study 30595777 — intervention group
Group type: COMPARATOR
Intervention: Conventional radiofrequency
Number of subjects: 118
Study 26985605 — intervention group
Group type: EXPERIMENTAL
Intervention: Lectures plus print (n=361)
Number of subjects: 756
Study 26985605 — intervention group
Group type: COMPARATOR
Intervention: Print (n=357)
Number of subjects: 756
Study 24935075 — intervention group
Group type: EXPERIMENTAL
Intervention: Senior work-up assessment and treatment (SWAT) model of care
Number of subjects: 1737
Study 24935075 — intervention group
Group type: COMPARATOR
Intervention: Non-SWAT control
Number of subjects: 1737
Study 24935075 — intervention group
Group type: COMPARATOR
Intervention: Standard of care control
Number of subjects: 1737
Study 24935075 — intervention group
Group type: COMPARATOR
Intervention: SWAT, non-SWAT, and standard of care control
Number of subjects: 1737
Study 23259259 — intervention group
Group type: EXPERIMENTAL
Intervention: Acupuncture and moxibustion
Number of subjects: 151
Study 20541900 — intervention group
Group type: EXPERIMENTAL
Intervention: Transdermal buprenorphine patches (5, 10, and 20 microg/hour)
Number of subjects: 246
Study 20541900 — intervention group
Group type: COMPARATOR
Intervention: Sublingual buprenorphine (200 and 400 microg tablets)
Number of subjects: 246
Study 18175753 — intervention group
Group type: EXPERIMENTAL
Intervention: Daily chocolate consumption (>=1 time/d)
Number of subjects: 1001
Study 18175753 — intervention group
Group type: COMPARATOR
Intervention: <1 time/wk chocolate consumption
Number of subjects: 1001
Study 16492107 — intervention group
Group type: EXPERIMENTAL
Intervention: 5 nicotine-containing cigarettes
Number of subjects: 60
Study 16492107 — intervention group
Group type: EXPERIMENTAL
Intervention: 5 denicotinized cigarettes
Number of subjects: 60
Study 16492107 — intervention group
Group type: COMPARATOR
Intervention: No lapse (abstinence)
Number of subjects: 60
Study 12773837 — intervention group
Group type: EXPERIMENTAL
Intervention: Children of parents with depression
Number of subjects: 8360
Study 12773837 — intervention group
Group type: COMPARATOR
Intervention: Children of parents without depression
Number of subjects: 8360
Study 10935148 — intervention group
Group type: EXPERIMENTAL
Intervention: Neuroleptanalgesia (0.025 mg fentanyl and 1.25 mg droperidol)
Number of subjects: 112
Study 10935148 — intervention group
Group type: COMPARATOR
Intervention: Morphine (10 mg initial dose, followed by 5 mg every 4 hours)
Number of subjects: 112
Study 9167897 — intervention group
Group type: EXPERIMENTAL
Intervention: AvaII polymorphism of the apo CII gene
Number of subjects: 226
Study 9167897 — intervention group
Group type: COMPARATOR
Intervention: apo E polymorphism
Number of subjects: 226
Study 8459266 — intervention group
Group type: COMPARATOR
Intervention: 5-fluorouracil (5-FU)
Number of subjects: 150
Study 8459266 — intervention group
Group type: EXPERIMENTAL
Intervention: 5-fluorouracil (5-FU) plus folinic acid (FA)
Number of subjects: 150
Study 3515526 — intervention group
Group type: EXPERIMENTAL
Intervention: Enteric-coated naproxen tablets (500 mg)
Number of subjects: 29
Study 3515526 — intervention group
Group type: COMPARATOR
Intervention: Plain naproxen tablets (500 mg)
Number of subjects: 29
Study 31409355 — intervention group
Group type: EXPERIMENTAL
Intervention: Low-frequency electrical stimulation combined with traditional bladder function training
Number of subjects: 91
Study 31409355 — intervention group
Group type: COMPARATOR
Intervention: Traditional bladder training (Control)
Number of subjects: 91
Study 31409355 — intervention group
Group type: EXPERIMENTAL
Intervention: Low-frequency electrical stimulation
Number of subjects: 91
Study 30067488 — intervention group
Group type: EXPERIMENTAL
Intervention: Rapid atrial pacing during ablation lesions
Number of subjects: 20
Study 30067488 — intervention group
Group type: COMPARATOR
Intervention: No pacing during ablation lesions
Number of subjects: 20
Study 27107490 — intervention group
Group type: EXPERIMENTAL
Intervention: ICS plus theophylline 100 mg bid
Number of subjects: 70
Study 27107490 — intervention group
Group type: COMPARATOR
Intervention: Matched placebo
Number of subjects: 70
Study 25178899 — intervention group
Group type: EXPERIMENTAL
Intervention: Body-as-process video
Number of subjects: 91
Study 25178899 — intervention group
Group type: EXPERIMENTAL
Intervention: Body-as-object video
Number of subjects: 91
Study 25178899 — intervention group
Group type: COMPARATOR
Intervention: Neutral video
Number of subjects: 91
Study 22749428 — intervention group
Group type: EXPERIMENTAL
Intervention: Prostate intensity-modulated radiotherapy (IMRT)
Number of subjects: 94
Study 22749428 — intervention group
Group type: COMPARATOR
Intervention: Erectile tissue-sparing IMRT technique
Number of subjects: 94
Study 20951305 — intervention group
Group type: EXPERIMENTAL
Intervention: 0.2-mm voxel resolution
Number of subjects: 180
Study 20951305 — intervention group
Group type: EXPERIMENTAL
Intervention: 0.3-mm voxel resolution
Number of subjects: 180
Study 20951305 — intervention group
Group type: COMPARATOR
Intervention: Gutta-percha
Number of subjects: 180
Study 20951305 — intervention group
Group type: COMPARATOR
Intervention: Cast-gold posts
Number of subjects: 180
Study 17352751 — intervention group
Group type: EXPERIMENTAL
Intervention: Mepilex (Molnlycke Health Care AB)
Number of subjects: 156
Study 17352751 — intervention group
Group type: COMPARATOR
Intervention: Allevyn Hydrocellular (Smith & Nephew)
Number of subjects: 156
Study 17352751 — intervention group
Group type: EXPERIMENTAL
Intervention: Both dressings
Number of subjects: 156
Study 17352751 — intervention group
Group type: EXPERIMENTAL
Intervention: Mepilex
Number of subjects: 156
Study 17352751 — intervention group
Group type: COMPARATOR
Intervention: Allevyn
Number of subjects: 156
Study 15649831 — intervention group
Group type: EXPERIMENTAL
Intervention: Acupuncture treatment (manual acupuncture at Y point on the neck, 4 sessions over 2 weeks)
Number of subjects: 326
Study 15649831 — intervention group
Group type: COMPARATOR
Intervention: No-treatment control
Number of subjects: 326
Study 11322870 — intervention group
Group type: EXPERIMENTAL
Intervention: Carvedilol
Number of subjects: 0
Study 11322870 — intervention group
Group type: COMPARATOR
Intervention: Metoprolol
Number of subjects: 0
Study 11322870 — intervention group
Group type: COMPARATOR
Intervention: Bisoprolol
Number of subjects: 0
Study 11322870 — intervention group
Group type: COMPARATOR
Intervention: Celiprolol
Number of subjects: 0
Study 11322870 — intervention group
Group type: COMPARATOR
Intervention: Carvedilol vs Metoprolol
Number of subjects: 0
Study 9539185 — intervention group
Group type: EXPERIMENTAL
Intervention: Low-energy diet (4.2 MJ/d)
Number of subjects: 121
Study 9539185 — intervention group
Group type: EXPERIMENTAL
Intervention: Low-energy diet + standardized physical exercise
Number of subjects: 121
Study 9539185 — intervention group
Group type: COMPARATOR
Intervention: No intervention (control)
Number of subjects: 121
Study 7864327 — intervention group
Group type: EXPERIMENTAL
Intervention: Higher concentration of bupivacaine combined with fentanyl
Number of subjects: 0
Study 7864327 — intervention group
Group type: EXPERIMENTAL
Intervention: Lower concentration of bupivacaine combined with fentanyl
Number of subjects: 0
Study 2598986 — intervention group
Group type: EXPERIMENTAL
Intervention: Cimetropium bromide (5 mg.h‐1)
Number of subjects: 8
Study 2598986 — intervention group
Group type: COMPARATOR
Intervention: Saline infusion with caerulein (10‐40 ng.kg‐1.h‐1)
Number of subjects: 8
Study 16115390 — intervention group
Group type: EXPERIMENTAL
Intervention: Theophylline 0.2 g twice a day for one month (group CA)
Number of subjects: 40
Study 16115390 — intervention group
Group type: COMPARATOR
Intervention: No theophylline (group CB)
Number of subjects: 40
Study 16115390 — intervention group
Group type: COMPARATOR
Intervention: Healthy non-smokers (group H)
Number of subjects: 40
Study 31418538 — intervention group
Group type: EXPERIMENTAL
Intervention: Rolapitant (single dose range, 9-180 mg)
Number of subjects: 482
Study 31418538 — intervention group
Group type: EXPERIMENTAL
Intervention: Rolapitant metabolite M19
Number of subjects: 482
Study 28273591 — intervention group
Group type: EXPERIMENTAL
Intervention: Nutrition education intervention for caregivers (initial sessions and monthly monitoring for 6 months)
Number of subjects: 190
Study 28273591 — intervention group
Group type: EXPERIMENTAL
Intervention: Nutrition education intervention for caregivers
Number of subjects: 190
Study 25591131 — intervention group
Group type: EXPERIMENTAL
Intervention: Off-axis elliptical training program
Number of subjects: 12
Study 23701174 — intervention group
Group type: EXPERIMENTAL
Intervention: Large muscle group exercises first (LG-SM)
Number of subjects: 16
Study 23701174 — intervention group
Group type: COMPARATOR
Intervention: Small muscle group exercises first (SM-LG)
Number of subjects: 16
Study 21261971 — intervention group
Group type: EXPERIMENTAL
Intervention: Comprehensive treatment of MTrPs including manual compression, manual stretching, intermittent cold application, home exercises, and ergonomic advice.
Number of subjects: 0
Study 21261971 — intervention group
Group type: EXPERIMENTAL
Intervention: Comprehensive treatment of MTrPs.
Number of subjects: 0
Study 19934922 — intervention group
Group type: EXPERIMENTAL
Intervention: Preoperative radiotherapy
Number of subjects: 364
Study 19934922 — intervention group
Group type: EXPERIMENTAL
Intervention: Reconstruction with a J-pouch
Number of subjects: 364
Study 19934922 — intervention group
Group type: COMPARATOR
Intervention: No radiotherapy
Number of subjects: 364
Study 16960170 — intervention group
Group type: EXPERIMENTAL
Intervention: Tomato extract (6TE)
Number of subjects: 90
Study 16960170 — intervention group
Group type: EXPERIMENTAL
Intervention: Tomato extract (2TE)
Number of subjects: 90
Study 16960170 — intervention group
Group type: COMPARATOR
Intervention: Control supplements
Number of subjects: 90
Study 14993543 — intervention group
Group type: EXPERIMENTAL
Intervention: Nutrient-enriched formula
Number of subjects: 474
Study 14993543 — intervention group
Group type: COMPARATOR
Intervention: Standard formula
Number of subjects: 474
Study 14993543 — intervention group
Group type: COMPARATOR
Intervention: Breastfed
Number of subjects: 474
Study 11726005 — intervention group
Group type: EXPERIMENTAL
Intervention: Sildenafil citrate (25-100 mg/d)
Number of subjects: 247
Study 11726005 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 247
Study 9221017 — intervention group
Group type: EXPERIMENTAL
Intervention: Loratadine (second generation anti-histamine)
Number of subjects: 0
Study 8422185 — intervention group
Group type: EXPERIMENTAL
Intervention: Idarubicin
Number of subjects: 2
Study 8422185 — intervention group
Group type: COMPARATOR
Intervention: SM‐5887, KRN‐8602, ME‐2303
Number of subjects: 2
Study 8422185 — intervention group
Group type: EXPERIMENTAL
Intervention: CI‐941
Number of subjects: 2
Study 2889079 — intervention group
Group type: EXPERIMENTAL
Intervention: Intravenous streptokinase (SK)
Number of subjects: 11712
Study 2889079 — intervention group
Group type: COMPARATOR
Intervention: Control group (no SK)
Number of subjects: 11712
Study 31043815 — intervention group
Group type: EXPERIMENTAL
Intervention: Co-created patient education material (pem)
Number of subjects: 574
Study 31043815 — intervention group
Group type: COMPARATOR
Intervention: Expert-created patient education material (pem)
Number of subjects: 574
Study 27141849 — intervention group
Group type: EXPERIMENTAL
Intervention: Cold counter-irritation (4°C to 22°C)
Number of subjects: 13
Study 27141849 — intervention group
Group type: EXPERIMENTAL
Intervention: Chemical 'cold-like' counter-irritation with 40% L-menthol and 10% trans-cinnamaldehyde
Number of subjects: 13
Study 27141849 — intervention group
Group type: COMPARATOR
Intervention: 5% doxepin (positive control)
Number of subjects: 13
Study 23889649 — intervention group
Group type: EXPERIMENTAL
Intervention: Whole Body Vibration (WBV) training, 3 times per week for 11 weeks
Number of subjects: 49
Study 23889649 — intervention group
Group type: COMPARATOR
Intervention: Control group (no intervention)
Number of subjects: 49
Study 21445242 — intervention group
Group type: EXPERIMENTAL
Intervention: SF-36 vitality scores at follow-up (mean of 64 weeks after stroke onset)
Number of subjects: 1080
Study 21445242 — intervention group
Group type: EXPERIMENTAL
Intervention: Female sex, increasing age, lower mental health, and lower emotional role function scores
Number of subjects: 1080
Study 19837254 — intervention group
Group type: EXPERIMENTAL
Intervention: Prophylactic paracetamol (3 doses every 6-8 hours in the first 24 hours)
Number of subjects: 459
Study 19837254 — intervention group
Group type: COMPARATOR
Intervention: No prophylactic paracetamol
Number of subjects: 459
Study 19837254 — intervention group
Group type: EXPERIMENTAL
Intervention: Prophylactic paracetamol
Number of subjects: 459
Study 16387819 — intervention group
Group type: EXPERIMENTAL
Intervention: Rhythm control
Number of subjects: 183
Study 16387819 — intervention group
Group type: COMPARATOR
Intervention: Rate control
Number of subjects: 183
Study 12548508 — intervention group
Group type: EXPERIMENTAL
Intervention: Tacrolimus, 20 ng/mL, plus Plasma‐lyte A liver flush solution
Number of subjects: 20
Study 12548508 — intervention group
Group type: COMPARATOR
Intervention: Plasma‐lyte A (placebo)
Number of subjects: 20
Study 11460282 — intervention group
Group type: EXPERIMENTAL
Intervention: Cervitec varnish
Number of subjects: 24
Study 11460282 — intervention group
Group type: COMPARATOR
Intervention: Placebo varnish
Number of subjects: 24
Study 9089994 — intervention group
Group type: EXPERIMENTAL
Intervention: Piggy-back technique
Number of subjects: 39
Study 9089994 — intervention group
Group type: COMPARATOR
Intervention: Traditional method (venovenous bypass)
Number of subjects: 39